
January 2, 2024
RegMed Investors (RMi) Research Note: Voyager Therapeutics (VYGR) juices after Novartis (NVS) licensing deal
January 2, 2024
RegMed Investors’ (RMi) pre-open: Defining the metrics for investors
December 29, 2023
RegMed Investors (RMi) Closing Bell: the last session’s hourglass slips empty
December 29, 2023
RegMed Investors’ (RMi) pre-open: on any note, lets end 2023
December 28, 2023
RegMed Investors (RMi) Closing Bell: The volatility tug-of-war
December 28, 2023
RegMed Investors’ (RMi) pre-open: “our” universe’s trend remains in a constant correction
December 27, 2023
RegMed Investors (RMi) Closing Bell: a Santa Claus rally in a short week of pitstops
December 27, 2023
RegMed Investors’ (RMi) pre-open: 2023 is almost over, truly a Homeric feat
December 26, 2023
RegMed Investors (RMi) Closing Bell: holiday cheer is still with us as cell and gene therapy sector continues to cascade
December 22, 2023
RegMed Investors (RMi) Closing Bell: Happy Hanukkah, Merry Christmas and Holiday; travel safe
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors